Fiduciary Family Office LLC bought a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 8,880 shares of the company's stock, valued at approximately $832,000.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in CL. Personal CFO Solutions LLC bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $285,000. Vision Capital Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $322,000. Autumn Glory Partners LLC boosted its holdings in shares of Colgate-Palmolive by 67.4% during the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company's stock worth $851,000 after buying an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. bought a new position in shares of Colgate-Palmolive during the 1st quarter worth approximately $2,166,000. Finally, Summit Investment Advisors Inc. boosted its holdings in shares of Colgate-Palmolive by 10.8% during the 4th quarter. Summit Investment Advisors Inc. now owns 32,710 shares of the company's stock worth $2,974,000 after buying an additional 3,187 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on CL shares. Wells Fargo & Company cut their price target on Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a report on Monday, August 4th. Wall Street Zen cut Colgate-Palmolive from a "buy" rating to a "hold" rating in a report on Wednesday, May 7th. UBS Group cut their target price on Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a report on Thursday, July 17th. Citigroup cut their target price on Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a report on Monday, August 4th. Finally, Morgan Stanley dropped their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $98.92.
View Our Latest Analysis on Colgate-Palmolive
Colgate-Palmolive Stock Performance
CL traded up $0.47 during trading hours on Tuesday, hitting $84.92. The stock had a trading volume of 5,191,470 shares, compared to its average volume of 5,262,051. The company's fifty day simple moving average is $88.61 and its 200 day simple moving average is $90.14. Colgate-Palmolive Company has a 1 year low of $82.40 and a 1 year high of $109.30. The stock has a market cap of $68.63 billion, a PE ratio of 23.85, a price-to-earnings-growth ratio of 4.41 and a beta of 0.35. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79.
Colgate-Palmolive (NYSE:CL - Get Free Report) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The company had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter last year, the firm posted $0.91 EPS. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.
Colgate-Palmolive Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a $0.52 dividend. The ex-dividend date is Friday, July 18th. This represents a $2.08 annualized dividend and a yield of 2.4%. Colgate-Palmolive's dividend payout ratio (DPR) is currently 58.43%.
Colgate-Palmolive Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Featured Stories

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.